Bridging the Gap Between Participants and Clinical Trials

I7P-MC-DSAF: Moderate to Severe Hidradenitis Suppurativa

CONDITION

Skin

GENDER

All

AGE GROUP

From 18

to 75 years

STATUS

Active, not recruiting

A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Studies Contact Form

Name*
First Last
Email*
Phone Number
Message*
CAPTCHA
- Send me updates about clinical trials
This field is hidden when viewing the form
All
- All

Approved By: Bellberry limited

Clinical Trial Registry Link: